XDH and diabetes mellitus: Allopurinol (ALP), a xanthine oxidase (XO) inhibitor, attenuated the diabetes-induced increased myocardial XO activity [8] and ROS production, and decreased oxidative/nitrosative stress, improving diabetes-induced cardiac dysfunction [9].